Trials / Sponsors / Wellstat Therapeutics
Wellstat Therapeutics
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Open-Label Study of Uridine Triacetate in Pediatric Patients With Hereditary Orotic Aciduria Hereditary Orotic Aciduria | Phase 3 | 2014-04-01 |
| Completed | Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 2 | 2005-05-01 |
| Completed | Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Type 2 Diabetes Mellitus | Phase 2 | 2005-04-01 |
| Terminated | Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors Solid Tumors | Phase 1 | 2002-08-01 |
| Completed | Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Adv Drug/Agent Toxicity by Tissue/Organ, Pancreatic Cancer | Phase 3 | 2001-02-01 |
| Approved For Marketing | Uridine Triacetate as Antidote for Patients at Excess Risk of 5-FU Toxicity Due to Overdosage or Impaired Elim Toxicity Due to Chemotherapy | — | — |